Syntara Limited has released a press release.
Chairmans Address to Shareholders
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Syntara
- Research Collaboration with Woolcock Institute
- S&P DJ Indicies Announces March Quarterly Rebalance
- Pharmaxis Announces Russian Approval for Bronchitol
- Pharmaxis Completes Recruitment of CF Clinical Trial for US
- Appendix 4C - quarterly March 2016
Later from Syntara
- Synairgen Collaboration Progress
- Quarterly Shareholder Update March 2017
- Appendix 4C - quarterly cash flow
- Pharmaxis Appoints Chiesi as Bronchitol Distributor in Italy
- Pharmaxis Set to Generate Further Euro 10m Milestone Payment
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara